DATROWAY ® (datopotamab deruxtecan) has been approved in the European Union (EU) for the treatment of adult patients with unresectable or metastatic hormone receptor (HR) positive, HER2 negative ...

BNT327 combined with chemotherapy showed an overall response rate of 85.4% when used as a first-line treatment for extensive-stage small cell lung cancer. Early trial results show combining the ...

The giant moa, an extinct group of flightless birds native to New Zealand, once reigned as one of the tallest and most impressive avian species in the world. Standing up to 3.6 meters (about 12 feet) ...

As with all products, the MHRA will keep its safety under close review. The Medicines and Healthcare products Regulatory Agency (MHRA) has today (9 April 2025) approved trastuzumab deruxtecan (Enhertu ...

Daiichi Sankyo is responsible for the manufacturing and supply of Datroway and retains exclusive rights for the treatment in the Japanese market. Datroway, also known as datopotamab deruxtecan, is an ...

Datroway, also known as datopotamab deruxtecan, is an antibody drug conjugate. The treatment has now been approved in the EU to treat adult patients with unresectable or metastatic hormone ...

例如，曲妥珠单抗德鲁昔康（trastuzumab deruxtecan）在 HER2 低表达的肿瘤中也展现出显著的临床活性。这就使得重新评估 HER2 检测标准成为必然，尤其是对于 HER2 低表达肿瘤的检测。传统的检测方法在判断 HER2 低表达肿瘤时存在一定的局限性，而新型药物的出现迫切 ...

The FDA has granted 501(k) clearance to ZEISS INTRABEAM 700, a robotic-assisted platform designed to enhance intraoperative radiation therapy. The FDA granted 510(k) clearance to ZEISS INTRABEAM 700 ...

TOKYO, Japan & MUNICH, Germany I April 08, 2025 I DATROWAY ® (datopotamab deruxtecan) has been approved in the European Union (EU) for the treatment of adult patients with unresectable or metastatic ...

First approval in the EU for Daiichi Sankyo and AstraZeneca’s DATROWAY based on TROPION-Breast01 trial showing 37% reduction in the risk of disease progression or death versus chemotherapy ...

RINVOQ is the first and only oral Janus kinase (JAK) inhibitor approved in the European Union (EU) to treat adult patients with giant cell arteritis (GCA) The approval is supported by data from ...